Transcriptomics Technologies

Global Market Trajectory & Analytics

MCP15286

EXECUTIVE ENGAGEMENTS

POOL

2833
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

512
Interactions with Platform & by Email

PARTICIPANTS

83
Unique # Participated

VALIDATIONS

24
Responses Validated*

COMPANIES

42
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

159

PAGES

231

EDITION

7

PRICE

USD 4950

CODE

MCP15286


COMPETITIVE METRICS

COMPANY

D S N T

% *

Affymetrix, Inc.

Login Required

Agilent Technologies, Inc.

Login Required

Bio-Rad Laboratories, Inc.

Login Required

F. Hoffmann-La Roche AG

Login Required

Fluidigm Corporation

Login Required

GE Healthcare

Login Required

Illumina, Inc.

Login Required

MilliporeSigma

Login Required

QIAGEN GmbH

Login Required

Thermo Fisher Scientific, Inc.

Login Required

SUBMIT
* D = Dominant; S = Strong; N = Niche; T = Trivial
* Validated respondents are incentivized with cluster data
Note: Best viewed in Landscape Mode
VIEW ENTIRE POOL OF 42 COMPETITORS

Login to access data silos

  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Transcriptomics Technologies estimated at US$4.6 Billion in the year 2020, is projected to reach a revised size of US$10.9 Billion by 2027, growing at a CAGR of 13.1% over the analysis period 2020-2027. Microarray, one of the segments analyzed in the report, is projected to record a 11.2% CAGR and reach US$2.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Polymerase chain reaction (PCR) segment is readjusted to a revised 14.6% CAGR for the next 7-year period.
The Transcriptomics Technologies market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.9 Billion by the year 2027 trailing a CAGR of 12.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 11.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 9.6% CAGR.
In the global Sequencing Technologies segment, USA, Canada, Japan, China and Europe will drive the 12.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$776.9 Million in the year 2020 will reach a projected size of US$1.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.3 Billion by the year 2027.

SELECT PLAYERS

Affymetrix, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Fluidigm Corporation; GE Healthcare; Illumina, Inc.; MilliporeSigma; Qiagen NV; Thermo Fisher Scientific, Inc.

SEGMENTS

» End-Use (Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes, Other End-Uses) » Product Segment (Consumables, Instruments, Software, Services) » Technology (Microarray, Polymerase chain reaction (PCR), Sequencing Technologies, Other Technologies)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Transcriptomics Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Transcriptomics Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Transcriptomics Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Microarray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Microarray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Polymerase chain reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Polymerase chain reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Polymerase chain reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Sequencing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Sequencing Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Sequencing Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Pharmaceutical and biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Pharmaceutical and biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Pharmaceutical and biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Academic Research and Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Academic Research and Government Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Academic Research and Government Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
China Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
China Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Transcriptomics Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Transcriptomics Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Transcriptomics Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
France Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
France Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Transcriptomics Technologies by Technology - Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Transcriptomics Technologies by Technology - Percentage Breakdown of Value Sales for Microarray, Polymerase chain reaction (PCR), Sequencing Technologies and Other Technologies for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Transcriptomics Technologies by Product Segment - Consumables, Instruments, Software and Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Transcriptomics Technologies by Product Segment - Percentage Breakdown of Value Sales for Consumables, Instruments, Software and Services for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Transcriptomics Technologies by End-Use - Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Transcriptomics Technologies by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical and biotechnology Companies, Academic Research and Government Institutes and Other End-Uses for the Years 2012, 2020 & 2027
Total Companies Profiled: 42

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com